Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice

被引:417
作者
Orsó, E
Broccardo, C
Kaminski, WE
Böttcher, A
Liebisch, G
Drobnik, W
Götz, A
Chambenoit, O
Diederich, W
Langmann, T
Spruss, T
Luciani, MF
Rothe, G
Lackner, KJ
Chimini, G
Schmitz, G
机构
[1] Univ Regensburg, Inst Clin Chem & Lab Med, D-93042 Regensburg, Germany
[2] CNRS Marseille Luminy, INSERM, Ctr Immunol, Marseille 9, France
[3] Univ Regensburg, Lab Anim Facil, D-8400 Regensburg, Germany
基金
澳大利亚研究理事会;
关键词
D O I
10.1038/72869
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mutations in the gene encoding ATP-binding cassette transporter 1 (ABC1) have been reported in Tangier disease(1-3) (TD), an autosomal recessive disorder that is characterized by almost complete absence of plasma high-density lipoprotein (HDL), deposition of cholesteryl esters in the reticulo-endothelial system(4) (RES) and aberrant cellular lipid trafficking(5-12). We demonstrate here that mice with a targeted inactivation of Abc1 display morphologic abnormalities and perturbations in their lipoprotein metabolism concordant with TD. ABC1 is expressed on the plasma membrane and the Golgi complex, mediates apo-Al associated export of cholesterol and phospholipids from the cell, and is regulated by cholesterol flux. Structural and functional abnormalities in caveolar processing and the trans-Golgi secretory pathway of cells lacking functional ABC1 indicate that lipid export processes involving vesicular budding between the Golgi and the plasma membrane are severely disturbed.
引用
收藏
页码:192 / 196
页数:5
相关论文
共 30 条
  • [1] ASSMANN G, 1989, METABOLIC BASIS INHE, P1267
  • [2] BHAKDI S, 1995, J EXP MED, V182, P1959, DOI 10.1084/jem.182.6.1959
  • [3] The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
    Bodzioch, M
    Orsó, E
    Klucken, T
    Langmann, T
    Böttcher, L
    Diederich, W
    Drobnik, W
    Barlage, S
    Büchler, C
    Porsch-Özcürümez, M
    Kaminski, WE
    Hahmann, HW
    Oette, K
    Rothe, G
    Aslanidis, C
    Lackner, KJ
    Schmitz, G
    [J]. NATURE GENETICS, 1999, 22 (04) : 347 - 351
  • [4] INVIVO METABOLISM OF PROAPOLIPOPROTEIN-A-I IN TANGIER DISEASE
    BOJANOVSKI, D
    GREGG, RE
    ZECH, LA
    MENG, MS
    BISHOP, C
    RONAN, R
    BREWER, HB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (06) : 1742 - 1747
  • [5] Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
    Brooks-Wilson, A
    Marcil, M
    Clee, SM
    Zhang, LH
    Roomp, K
    van Dam, M
    Yu, L
    Brewer, C
    Collins, JA
    Molhuizen, HOF
    Loubser, O
    Ouelette, BFF
    Fichter, K
    Ashbourne-Excoffon, KJD
    Sensen, CW
    Scherer, S
    Mott, S
    Denis, M
    Martindale, D
    Frohlich, J
    Morgan, K
    Koop, B
    Pimstone, S
    Kastelein, JJP
    Genest, J
    Hayden, MR
    [J]. NATURE GENETICS, 1999, 22 (04) : 336 - 345
  • [6] CAVEOLIN CYCLES BETWEEN PLASMA-MEMBRANE CAVEOLAE AND THE GOLGI-COMPLEX BY MICROTUBULE-DEPENDENT AND MICROTUBULE-INDEPENDENT STEPS
    CONRAD, PA
    SMART, EJ
    YING, YS
    ANDERSON, RGW
    BLOOM, GS
    [J]. JOURNAL OF CELL BIOLOGY, 1995, 131 (06) : 1421 - 1433
  • [7] Growth and cell cycle abnormalities of fibroblasts from Tangier disease patients
    Drobnik, W
    Liebisch, G
    Biederer, C
    Trümbach, B
    Rogler, G
    Müller, P
    Schmitz, G
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (01) : 28 - 38
  • [8] Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers
    Fielding, CJ
    Bist, A
    Fielding, PE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 3753 - 3758
  • [9] PLASMA-MEMBRANE CAVEOLAE MEDIATE THE EFFLUX OF CELLULAR FREE-CHOLESTEROL
    FIELDING, PE
    FIELDING, CJ
    [J]. BIOCHEMISTRY, 1995, 34 (44) : 14288 - 14292
  • [10] DEFECTIVE REMOVAL OF CELLULAR CHOLESTEROL AND PHOSPHOLIPIDS BY APOLIPOPROTEIN-A-I IN TANGIER DISEASE
    FRANCIS, GA
    KNOPP, RH
    ORAM, JF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 78 - 87